Workshop speakers

Edward A. Dennis

San Diego, USA

Potential and caveats of lipidomics for cardiovascular disease

Mark Febbraio

Darlinghurst, Australia

Role of TLR4 in lipid induced macrophage inflammation

Robert Gerszten

Boston, USA

Mining the blood for new cardiometabolic markers

Albert K. Groen

Groningen, The Netherlands

The role of bile acids in cholesterol homeostatis

Nicholas J. Leeper

Boston, USA

The role of efferocytosis in atherosclerosis

Ziad Mallat

Cambridge, United Kingdom

Functional immune cell interactions and plaque development

Adil Mardinoglu

Stockholm, Sweden

Nonalcoholic liver hepatic steatosis: a systems biology approach

Willem J.M. Mulder

Maastricht, The Netherlands

Nanomedicine as novel atherosclerosis thearpy

Kiran Musunur

Philadelphia, USA

Genome editing strategies in cardiovascular diseases and cardiovascular study

Giuseppe D. Norata

Milan, Italy

PCSK9 biology beyond the liver

Gary K. Owens

Charlottesville, USA

Vascular smooth muscle cells in atherosclerosis

Michael Potente

Bad Nauheim, Germany

Transcriptional control of endothelial energy

Emilio Ros

Barcelona, Spain

Lessons from the "Prevention with Mediterranean Diet" (Predimed) study

Filip K. Swirski

Boston, USA

Distant control of plaque formation

Peter Tontonoz

Los Angeles, USA

Lipid signaling pathways in physiology and disease

Anne Tybjaerg-Hansen

Copenhagen, Denmark

Generic risk, adherence to a healthy lifestyle, and cardiovascular disease

Jan M. van Deursen

Rochester, USA

Senescent intimal foam cells are deleterious at all stages of atherosclerosis